Skip to main content

Table 2 Prevalence of K76T mutation per study site

From: Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance

SitePositive RDT/thick blood sample
N
Positive Pf PCR
N (%)
Samples successfully sequenced among positive Pf PCR
N
Samples with K76T mutant
N
Prevalence of K76T mutation % (95% CI)
Bolenge9873 (74.5)561832.1 (20.3–46.6)
Fungurume9265 (70.7)6511.5 (0.0–8.3)
Kalima9767 (69.1)6634.5 (0.9–12.7)
Kamina9873 (74.5)71811.3 (5.0–21.0)
Karawa9766 (68.0)54611.1 (4.2–22.6)
Katana10578 (74.3)766889.5 (80.3–95.3)
Kinshasa160160 (100)1607848.8 (40.8–56.8)
Kisangani12893 (72.7)8544.7 (1.3–11.6)
Lubumbashi10156 (55.4)5611.8 (0.0–9.6)
Vanga9475 (79.8)753141.3 (30.1–53.3)
Total1070806 (75.3)76421828.5 (25.4–31.9)
  1. N number; globally, there was a significant difference of K76T prevalence between sites (p < 0.001)